Patients with Hashimoto encephalitis may present with seizures, stroke-like episodes, transient focal and global neurological deficits, and a variety of neuropsychiatric disturbances. The encephalopathy evolves with elevated anti-thyroid peroxidase antibodies, independent of hormonal thyroid function. A teenager experienced repeated concussions antedating onset of Hashimoto encephalopathy. Neuroradiological studies showed overlapping areas of altered brain metabolism and vascular perfusion in the hippocampus, deemed most vulnerable in autoimmune encephalopathy. Concussive brain injury may be a contributing factor in the development of encephalopathy due to its capacity to alter the blood-brain barrier.
Introduction
Hashimoto thyroiditis and encephalopathy are extensively reviewed by Younger [1] . Neurologists have been pursuing the associated but rare encephalopathy associated with Hashimoto thyroiditis for over fifty years. In 1966, the British neurologist, Lord Brain and colleagues [2] described Hashimoto encephalopathy in a 40-year-old man with ictal and stroke-like episodes of confusion and agitation one year after onset of treated hypothyroidism, eventually resolving with the likeliest explanation of an antibody-mediated autoimmune etiopathogenesis.
Jellinek and Ball [3] extended the patient of Brain and colleagues [2] , who later died at age 62, 12 years after an unrelated cause. Autopsy showed no remaining thyroid tissue and atheromatous cerebrovascular changes with splenic atrophy. The authors [3] postulated an autoimmune disturbance as the cause of thyroiditis, encephalopathy, and splenic atrophy. In 2003, Rowland and colleagues [4] described the clinicopathologic findings of all literature cases of Hashimoto encephalopathy beginning with the patient described by Lord Brain and coworkers [2] , and adding their own patient.
The diagnosis of Hashimoto encephalopathy rests upon the presence of thyroiditis, with measurably high titers of thyroid peroxidase (TPO) or thyroglobulin (Tg) antibodies, clinical encephalopathy (as evidenced by clouding of consciousness with reduced wakefulness, attention, or cognitive function), and absent evidence of cerebrospinal fluid (CSF) bacterial or viral infection [4] . Historically, as now, it is unknown whether anti-thyroid antibodies and thyroid dysfunction contribute to the pathogenesis of encephalopathy. 
Case Report

Discussion
A relation of Hashimoto encephalopathy to vasculitis was postulated in two cases studied histologically at autopsy showing lymphocytic infiltration of brainstem veins [5] , while brain biopsy tissue of another patient showed lymphocytic infiltration of the walls of cerebral arterioles and veins [6] . Brain biopsy tissue in the patient described by Rowland and coworkers [4] showed perivascular cuffs of lymphocytic cells [4] .
Ochi and colleagues [7] associated Hashimoto encephalopathy-related pathology and corticosteroid sensitivity with the novel antigen, α-enolase, encoded at the 1p36.23 locus. Kishitani and coworkers [8] Closed-head impact injury in experimental animals is associated with impaired axonal conduction in bilateral mesial hippocampal cells of the stratum alveus [11] . An assay that detects elevated serum levels of ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) (ClinicalTrials.gov identifier number, NCT01426919) within 12 hours of concussive head injury is associated with neuronal injury and BBB changes, and predicts the need for neuroradiologic intervention.
Conclusion
The terms Hashimoto thyroiditis and encephalopathy are deeply entrenched in the scientific literature. While the former is a cornerstone for understanding autoimmune thyroid disease, the latter remains a challenge to clinicians in elucidating the mediating factors that lead to its expression.
